ArticleBritish journal of cancer2026

Blocking mitochondrial leucine transamination enhances T-cell activation and improves T-cell immunity against OVA-producing EL4 lymphoma.

Christie M Adam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.